Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FE7K7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,575
Award facts
- Contract value 100% obligated
- $25,574.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,574.66 for Dupixent 300 mg/2 ml pens on November 24, 2025, with an ultimate completion date of November 25, 2025. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026. The contract will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
Dupixent (dupilumab) is a biologic immunosuppressant medication used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and moderate-to-severe asthma. This delivery order supports the Defense Health Agency's pharmaceutical supply chain for military healthcare beneficiaries. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains extensive federal contract relationships with DLA for supplying brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's $1 billion prime vendor contract exemplifies its critical role in ensuring consistent availability of specialized pharmaceutical products throughout the Department of Defense medical supply chain globally.
Quick answers
Who was awarded contract SPE2DR26FE7K7?
SPE2DR26FE7K7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FE7K7 worth?
The government has obligated $25,575 on SPE2DR26FE7K7.
Is contract SPE2DR26FE7K7 an order under another contract?
Yes. SPE2DR26FE7K7 is a delivery order under SPE2DR25D2005, an indefinite delivery contract.
Was contract SPE2DR26FE7K7 competed?
The extent of competition for SPE2DR26FE7K7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award